Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013496 |
---|---|
Receipt number | R000015764 |
Scientific Title | Effect of intravenous immunoglobulin (IVIG) in pregnant women with refractory obstetric antiphospholipid syndrome: A prospective single-arm interventional study |
Date of disclosure of the study information | 2014/03/25 |
Last modified on | 2023/03/15 12:39:00 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/03/24 13:37:53 | ||
2 | Update | 2014/03/24 19:57:32 | Interventions/Control_1 Interventions/Control_1 |
|
3 | Update | 2014/03/24 20:00:47 | Date of disclosure of the study information |
|
4 | Update | 2014/04/08 10:41:58 | UMIN ID1 |
|
5 | Update | 2014/04/08 10:44:49 | Recruitment status |
|
6 | Update | 2014/07/04 19:35:28 | Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2014/07/04 19:41:33 | Name of person sending information Name of person sending information |
|
8 | Update | 2015/03/27 18:28:32 | Recruitment status |
|
9 | Update | 2016/06/01 11:02:05 | UMIN ID2 |
|
10 | Update | 2016/07/24 13:15:50 | Study type Key inclusion criteria Key inclusion criteria Target sample size |
|
11 | Update | 2016/07/24 13:17:18 | Key inclusion criteria Key inclusion criteria |
|
12 | Update | 2016/07/24 13:27:19 | Name of primary person or sponsor Organization Organization Category of Funding Organization Institutions |
|
13 | Update | 2016/09/24 15:50:39 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
14 | Update | 2016/09/24 16:02:39 | Primary outcomes Primary outcomes |
|
15 | Update | 2016/09/24 16:04:34 | Last name of contact person Last name of contact person Division name Division name |
|
16 | Update | 2016/09/24 16:05:44 | Institutions |
|
17 | Update | 2018/10/02 23:22:34 | Institutions |
|
18 | Update | 2022/03/31 21:16:33 | Recruitment status Date of IRB Last follow-up date |
|
19 | Update | 2022/03/31 21:17:05 | Number of participants that the trial has enrolled |
|
20 | Update | 2022/03/31 21:23:38 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Organization Zip code Address Address TEL Organization Organization Address Address Tel |
|
21 | Update | 2022/09/29 19:27:12 | Institutions |
|
22 | Update | 2022/09/29 19:29:04 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
23 | Update | 2023/03/15 12:39:00 | Recruitment status |